Recombinant Human CES2/carboxylesterase 2 Protein (HEK293)，His

Carboxylesterase 2 (CES2) is a crucial enzyme involved in the hydrolysis of various esters, amides, and prodrugs, playing a significant role in drug metabolism and detoxification processes. Its importance is underscored by its involvement in the pharmacokinetics of numerous therapeutic agents, including angiotensin-converting enzyme inhibitors and anti-cancer drugs. Given the variability in CES2 activity among individuals due to genetic polymorphisms and environmental factors, research into CES2 is essential for understanding inter-individual differences in drug efficacy and toxicity. Recombinant CES2 protein production has become a focal point in enzymology, pharmacology, and drug development, facilitating in vitro studies that elucidate the enzyme's substrate specificity, catalytic mechanisms, and potential for generating drug-drug interactions. Moreover, the engineering of CES2 through recombinant technology has opened avenues for enhancing its enzymatic properties, aiding in the development of tailored therapeutics with improved profiles. Understanding CES2’s structure-function relationship is pivotal for the design of new drugs and optimizing existing ones, making it a critical target for both academic research and pharmaceutical applications.